CD36 and cancer: Altered lipid metabolism is one of the most important hallmarks of cancer metastasis initiation 38, and CD36 was previously identified as the dominant regulator that may link the bioenergetic pathway to oncogenic signaling through regulatory factors involved in lipid metabolic reprogramming in cancer cells12, 37.